@article{article, title  = {{Cost-effectiveness of bivalirudin versus heparin plus glycoprotein IIb/IIIa inhibitor in the treatment of non-ST-segment elevation acute coronary syndromes}},

 url = {{}},

 year = {{2011}},

 month = {{1}},

 author = {{Schwenkglenks M and Brazier JE and Szucs TD and Fox KAA}},

 doi = {{10.1016/j.jval.2010.10.025}},

 volume = {{14}},

 journal = {{VALUE IN HEALTH}},

 issue = {{1}},

 pages = {{24-33}},

 note = {{Accessed on 2025/03/17}}}